Superworth

Xtant Medical price to book ratio XTNT

Market value divided by the book value of the company's net assets, since 2011.

Today, Oct 23, 2026
1.0×
8-year median
2.1×
Against its 8-year history
0th
percentile: 0 is its lowest day, 100 its highest
8-year range
1.0× to 23.2×
Peer median
2.6×

Xtant Medical's price to book ratio is 1.0× as of Oct 23, 2026.

That is below its 8-year median of 2.1×, lower than on 100% of days in the last 8 years.

Over that time it ranged from 1.0× in Oct 2026 to 23.2× in Feb 2021.

The median for 7 medical instruments and supplies stocks of a similar size is 2.6×.

Price to book ratio over time

The dashed line is the 8-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far1.0×1.0×2.1×
20252.2×1.3×2.4×
20241.4×1.1×2.8×
20232.7×1.9×5.5×
20222.2×1.4×2.5×
20211.5×1.5×23.2×
2020n/m a value too high to mean anything
20193.2×2.3×4.6×
20182.4×2.4×7.5×
2017n/m a value too high to mean anything
20166.7×2.7×7.8×
2015n/m a value too high to mean anything
2014n/m a value too high to mean anything
20136.9×4.2×13.5×
20126.6×5.3×19.0×
201113.4×7.8×14.5×

Against its peers

Companies in Medical - Instruments & Supplies nearest Xtant Medical's size, closest first, today.

CompanyPrice to book ratio
XTNTXtant Medical1.0×
NEPHNephros3.2×
APTAlpha Pro Tech0.9×
KEQUKewaunee Scientific1.3×
PDEXPro DEX4.2×
UTMDUtah Medical Products1.9×
INFUInfuSystem4.7×
EMBCEmbectan/m
Peer median2.6×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Xtant Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.